STONY BROOK, N.Y. (May 25, 2016) – Applied DNA Sciences (ADNAS), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, anti-theft technology products, genotyping and product authentication solutions, today named CGPR as their public relations agency of record for their textile and apparel business.
CGPR will provide strategic counsel to continue to drive awareness of its exciting textile and apparel DNA marking, validation and authentication platform. Major brands and supply chain partners are using the platform to ensure integrity of products and associated claims. The PR plan will compliment the demand creation plan in place and support the launch of new technologies, solutions and products.
“CGPR has robust component experience with iconic global brands including Microban, PrimaLoft and W.L. Gore & Associates,” said John Shearman, executive director of marketing for ADNAS. “Their expertise will help raise the visibility of ADNAS’ proprietary technologies and educate manufacturers, retailers and consumers to the benefits of their platform. CGPR will keep our technologies top of mind with key decision makers in the home textile and apparel communities, target growth categories for the coming year. We look forward to a long-term partnership.”
About CGPR: CGPR is a public relations firm with a consumer focus, leveraging a wide scope of expertise on behalf of clients that are established leaders in their industries. This enables the agency to utilize its years of experience across a wide variety of categories, including corporate communications, social media, government relations, crisis management, media relations and strategic planning. The agency, founded more than 23 years ago by Chris Ann Goddard, has a staff with a proven track record from both the agency and client perspectives. CGPR is headquartered in Marblehead, Mass., just outside of Boston. For more information, visit: www.cgprpublicrelations.com.
About Applied DNA Sciences: We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction. Go to adnas.comfor more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Debbie Bailey, 631-240-8817, email@example.com
Media contact: Kristen Bujold, 781-639-4924, firstname.lastname@example.org
Program contact: John Shearman, 631-240-8838, email@example.com